220 related articles for article (PubMed ID: 28112205)
1. A human immunodeficiency syndrome caused by mutations in CARMIL2.
Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
[TBL] [Abstract][Full Text] [Related]
2. A Novel Pathogenic Variant in
Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
Front Immunol; 2020; 11():884. PubMed ID: 32625199
[TBL] [Abstract][Full Text] [Related]
3. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
Front Immunol; 2018; 9():203. PubMed ID: 29479355
[TBL] [Abstract][Full Text] [Related]
4. Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations.
Maccari ME; Speckmann C; Heeg M; Reimer A; Casetti F; Has C; Ehl S; Castro CN
Clin Immunol; 2019 Nov; 208():108228. PubMed ID: 31195081
[TBL] [Abstract][Full Text] [Related]
5. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.
Roncagalli R; Cucchetti M; Jarmuzynski N; Grégoire C; Bergot E; Audebert S; Baudelet E; Menoita MG; Joachim A; Durand S; Suchanek M; Fiore F; Zhang L; Liang Y; Camoin L; Malissen M; Malissen B
J Exp Med; 2016 Oct; 213(11):2437-2457. PubMed ID: 27647348
[TBL] [Abstract][Full Text] [Related]
6. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
Lévy R; Gothe F; Momenilandi M; Magg T; Materna M; Peters P; Raedler J; Philippot Q; Rack-Hoch AL; Langlais D; Bourgey M; Lanz AL; Ogishi M; Rosain J; Martin E; Latour S; Vladikine N; Distefano M; Khan T; Rapaport F; Schulz MS; Holzer U; Fasth A; Sogkas G; Speckmann C; Troilo A; Bigley V; Roppelt A; Dinur-Schejter Y; Toker O; Bronken Martinsen KH; Sherkat R; Somekh I; Somech R; Shouval DS; Kühl JS; Ip W; McDermott EM; Cliffe L; Ozen A; Baris S; Rangarajan HG; Jouanguy E; Puel A; Bustamante J; Alyanakian MA; Fusaro M; Wang Y; Kong XF; Cobat A; Boutboul D; Castelle M; Aguilar C; Hermine O; Cheminant M; Suarez F; Yildiran A; Bousfiha A; Al-Mousa H; Alsohime F; Cagdas D; Abraham RS; Knutsen AP; Fevang B; Bhattad S; Kiykim A; Erman B; Arikoglu T; Unal E; Kumar A; Geier CB; Baumann U; Neven B; ; Rohlfs M; Walz C; Abel L; Malissen B; Marr N; Klein C; Casanova JL; Hauck F; Béziat V
J Exp Med; 2023 Feb; 220(2):. PubMed ID: 36515678
[TBL] [Abstract][Full Text] [Related]
7. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Shamriz O; Simon AJ; Lev A; Megged O; Ledder O; Picard E; Joseph L; Molho-Pessach V; Tal Y; Millman P; Slae M; Somech R; Toker O; Berger M
Clin Exp Immunol; 2020 Jun; 200(3):215-227. PubMed ID: 32201938
[TBL] [Abstract][Full Text] [Related]
8. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
[TBL] [Abstract][Full Text] [Related]
9. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
Wang Y; Ma CS; Ling Y; Bousfiha A; Camcioglu Y; Jacquot S; Payne K; Crestani E; Roncagalli R; Belkadi A; Kerner G; Lorenzo L; Deswarte C; Chrabieh M; Patin E; Vincent QB; Müller-Fleckenstein I; Fleckenstein B; Ailal F; Quintana-Murci L; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Puel A; Bustamante J; Boisson-Dupuis S; Malissen M; Malissen B; Abel L; Hovnanian A; Notarangelo LD; Jouanguy E; Tangye SG; Béziat V; Casanova JL
J Exp Med; 2016 Oct; 213(11):2413-2435. PubMed ID: 27647349
[TBL] [Abstract][Full Text] [Related]
10. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
[TBL] [Abstract][Full Text] [Related]
11. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
[TBL] [Abstract][Full Text] [Related]
12. Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers.
Marangi G; Garcovich S; Sante GD; Orteschi D; Frangella S; Scaldaferri F; Genuardi M; Peris K; Gurrieri F; Zollino M
Acta Derm Venereol; 2020 Jan; 100(1):adv00038. PubMed ID: 31709449
[No Abstract] [Full Text] [Related]
13. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
[TBL] [Abstract][Full Text] [Related]
14. Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association.
Yee CS; Massaad MJ; Bainter W; Ohsumi TK; Föger N; Chan AC; Akarsu NA; Aytekin C; Ayvaz DÇ; Tezcan I; Sanal Ö; Geha RS; Chou J
J Allergy Clin Immunol; 2016 Mar; 137(3):879-88.e2. PubMed ID: 26476480
[TBL] [Abstract][Full Text] [Related]
15. A Novel CARMIL2 Mutation Resulting in Combined Immunodeficiency Manifesting with Dermatitis, Fungal, and Viral Skin Infections As Well as Selective Antibody Deficiency.
Atschekzei F; Jacobs R; Wetzke M; Sogkas G; Schröder C; Ahrenstorf G; Dhingra A; Ott H; Baumann U; Schmidt RE
J Clin Immunol; 2019 Apr; 39(3):274-276. PubMed ID: 31001706
[No Abstract] [Full Text] [Related]
16. Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy.
Zhu Y; Ye L; Huang H; Xu X; Liu Y; Wang J; Jin Y
Front Pediatr; 2022; 10():1042302. PubMed ID: 36727012
[TBL] [Abstract][Full Text] [Related]
17. CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling.
Graham DB; Bell MP; Huntoon CJ; Griffin MD; Tai X; Singer A; McKean DJ
J Immunol; 2006 Nov; 177(9):6098-107. PubMed ID: 17056536
[TBL] [Abstract][Full Text] [Related]
18. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency.
Hauck F; Randriamampita C; Martin E; Gerart S; Lambert N; Lim A; Soulier J; Maciorowski Z; Touzot F; Moshous D; Quartier P; Heritier S; Blanche S; Rieux-Laucat F; Brousse N; Callebaut I; Veillette A; Hivroz C; Fischer A; Latour S; Picard C
J Allergy Clin Immunol; 2012 Nov; 130(5):1144-1152.e11. PubMed ID: 22985903
[TBL] [Abstract][Full Text] [Related]
19. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
[TBL] [Abstract][Full Text] [Related]
20. A potential founder variant in
Sorte HS; Osnes LT; Fevang B; Aukrust P; Erichsen HC; Backe PH; Abrahamsen TG; Kittang OB; Øverland T; Jhangiani SN; Muzny DM; Vigeland MD; Samarakoon P; Gambin T; Akdemir ZH; Gibbs RA; Rødningen OK; Lyle R; Lupski JR; Stray-Pedersen A
Mol Genet Genomic Med; 2016 Nov; 4(6):604-616. PubMed ID: 27896283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
